Navigation Links
Market Disruption Imminent as Hospitals and Physicians Aggressively Adopt Patient Portal Technology
Date:9/27/2013

MOUNTAIN VIEW, Calif., Sept. 27, 2013 /PRNewswire/ -- Approximately 50 percent of U.S. hospitals and 40 percent of U.S. physicians in ambulatory practice possess some type of patient portal technology, mostly acquired as a module of their practice management (PM) or electronic health record (EHR) system. While the availability of patient portals does not necessarily translate into active provider or patient use, the technology is emerging as the key platform for various efforts around patient engagement such as access to medical records, communication with providers, education, wellness tracking and e-visits.

New analysis from Frost & Sullivan's (http://www.healthcareIT.frost.com) U.S. Patient Portal Market for Hospitals and Physicians: Overview and Outlook, 2012–2017 predicts the market to grow significantly over the next five years. The total U.S. patient portal market for hospitals and physicians earned revenue of $279.8 million in 2012. This is expected to increase steadily, reaching $898.4 million in 2017, representing a 221.1 percent increase. The majority of revenue will primarily result from increased demand driven by myriad forces including the need to meet Stage 2 Meaningful Use (MU) requirements, the growing move to clinical integration and accountable care, and increasing consumer demand for health information technology.

For more information on this research, please email Jennifer Carson, Corporate Communications, at jennifer.carson@frost.com, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

Patient portals are Web-based applications enabling patients to interact and communicate with their healthcare providers. Patient portal adoption and active use is accelerating dramatically across the U.S., driven by Stage 2 MU requirements. These requirements are scheduled to begin in October 2013 for hospitals and January 2014 for physicians. Stage 2 MU requires providers to adopt and use technology that allows patients to electronically view, download and transmit electronic copies of their own medical records. Patient portals are the key technology that will help providers meet these requirements. In addition, providers that adopt patient portals will enjoy a competitive advantage as patients increasingly demand convenient, 24/7 access to their financial and clinical data.

"The need to fully engage patients as a member of the care team is fundamentally about encouraging individuals to become more involved with their healthcare, so they will be motivated to make behavioral changes that can positively impact their health status," said Frost & Sullivan Connected Health Principal Analyst Nancy Fabozzi. "That need will only grow as the healthcare system moves towards accountable care and value-based reimbursement. The importance of this movement cannot be underestimated." 

The majority of healthcare providers are primarily adopting patient portals that are built in or added on as a module to their PM or EHR system. This adoption era can be considered "Patient Portal 1.0." However, because the majority of solutions available today are not capable of providing the advanced interoperability and functionality needed to support clinical integration, accountable care and ongoing and sustainable patient engagement, significant disruption is forecasted in the years to come.

"As healthcare reform and transformation advances, providers will seek new ways to engage patients and influence behavior beyond the point of care and will increasingly look to the more advanced solutions that are proven to consistently motivate patient compliance and sustained behavioral change," concluded Fabozzi. "These solutions, which can be considered "Patient Portal 2.0," will have robust functions such as health information exchange across diverse care settings, integration of clinical and financial data, dynamic scheduling, social networking, gaming, avatars for personalized health coaching, and e-visits."

U.S. Patient Portal Market for Hospitals and Physicians: Overview and Outlook, 2012 – 2017 is part of the Connected Health Growth Partnership Service program, which also includes research in the following markets: health information exchange, health data analytics, telehealth, emerging wireless technologies, acute care information systems, enterprise clinical information systems, and billing and revenue cycle management systems. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Connect with Frost & Sullivan on social media, including Twitter, Facebook, SlideShare and LinkedIn, for the latest news and updates.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

U.S. Patient Portal Market for Hospitals and Physicians: Overview and Outlook, 2012 – 2017
NC61-48

Contact:
Jennifer Carson
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
E: jennifer.carson@frost.com

Twitter: @frost_sullivan
Facebook: Frost & Sullivan 
http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
2. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
3. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
4. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
7. Ophthalmic Drugs: World Market Prospects 2012-2022
8. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
9. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
10. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - Medicure Inc. ... Canadian specialty pharmaceutical company, is pleased to announce ... final approval from the U.S. Food and Drug ... application ("ANDA") for tetrabenazine tablets in the 12.5 ... product is a generic equivalent of the branded ...
(Date:3/23/2017)... The global dermatology devices market ... by 2025, according to a new report by Grand View ... faster rate due to rising concern amongst people regarding esthetics. ... esthetic procedures used for treating hair - and skin-related disorders. ... as the highest revenue generators for the market. ...
(Date:3/22/2017)... , 22 de marzo de 2017   ... líder de soluciones de productos y servicios para ... que ha adquirido EPL Archives, Inc., una organización ... clientes en todo el ciclo de vida de ... una muestra de archivo, almacenamiento de documentos y ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics ... serious so build on a solid foundation. As experts in dangerous situations the ... that is coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The American ... 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management ... who have contributed not only to the association, but also to the Health Care ...
(Date:3/23/2017)... Jersey (PRWEB) , ... March 23, 2017 , ... ... of herbal-based and non-steroidal skincare products, was awarded as winners of American Dreams ... products. This competition was hosted jointly by HSN and Good Housekeeping. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April ... , How will the new EU MDR language change the way manufacturers ...
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare Solutions ... at HCCA’s 21st annual Compliance Institute on March 26-28 in National Harbor, Maryland. ... all medical chart types with a comprehensive set of features including built-in workflow, ...
Breaking Medicine News(10 mins):